Wedbush Upgrades National Health Investors to Outperform, Raises Price Target to $64
Portfolio Pulse from Benzinga Newsdesk
Wedbush analyst Richard Anderson upgraded National Health Investors (NHI) from Neutral to Outperform and increased the price target from $57 to $64.

February 26, 2024 | 6:37 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Wedbush upgraded National Health Investors to Outperform and raised the price target to $64.
Upgrades by analysts, especially from neutral to outperform, typically signal a positive outlook on the stock, suggesting potential for price appreciation. The increase in price target further reinforces this positive sentiment, indicating an expectation of strong performance.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100